IBI311

· Innovent Biologics (Suzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for IBI311, covering 2024-02-08 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of IBI311 in Subjects With Steroid-resistant, Thyroid Associated Ophthalmopathy [Phase 3]